According to MarketsandMarkets™, the vitamin K2 market is projected to grow from USD 179.0 million in 2026 to reach USD 339.9 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period. Vitamin K2 demand is poised to grow steadily, backed by the rising consumer awareness regarding its benefits for bone and cardiovascular health, as well as healthy calcium metabolism. Unlike many nutrients, vitamin K2 helps to activate proteins that direct calcium into bones and teeth while reducing calcium accumulation in soft tissues, making it an important ingredient in dietary supplements and functional nutrition. Vitamin K2 is available in a wide variety of formats, including capsules, tablets, soft gels, powders, gummies, and fortified foods and beverages, and has countless applications, given its inclusion in combo products with vitamin D3, calcium, and other bone health nutrients. The increasing consumer affinity for preventive healthcare, healthy aging, clean-label formulations, and scientifically proven ingredients is expected to further propel the vitamin K2 market.
Market Size and Forecast:
- Market Size Value in 2025: USD 158.0 Million
- Market Size Value in 2026: USD 179 Million
- Revenue Forecast in 2031: USD 339.9 Million
- Growth Rate: CAGR of 13.7% from 2026 to 2031
- Data available from 2022 to 2031
- Base year: 2025
- Forecast period: 2026–2031
- The Asia Pacific region is projected to register the highest CAGR of 14.2% during the forecast period.
- The health supplements segment is estimated to account for the largest market share of 80.9% in 2026.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80962397
By source, the natural segment is expected to exhibit the fastest growth rate during the forecast period.
Naturally derived Vitamin K2, a product mainly obtained by bacterial fermentation, is perceivably much more bio-available and acceptable among consumers. Increasing appreciation for plant-based, non-GMO, and sustainable nutritional products has created an incremental demand for naturally derived Vitamin K2 as a key ingredient for its inclusion in dietary supplements, functional foods, and pharmaceutical applications. Apart from this, manufacturers are heavily investing in advanced fermentation techniques to proliferate the quality and scale of products, while regulatory support and increasing confidence among consumers for naturally sourced ingredients are also favoring the growth of this segment.
By application, the pharmaceuticals segment is projected to record the highest CAGR during the forecast period.
Increasing clinical research is validating the role of vitamin K2 in bone health, osteoporosis treatment, cardiovascular health, and other applications. Healthcare providers are incorporating Vitamin K2, particularly in combination with Vitamin D3 and calcium, into therapeutic regimens to improve bone mineralization and reduce fracture risk, especially among aging populations. Further, as research on Vitamin K2, especially in helping to prevent vascular calcification and chronic disease, continues, pharmaceutical companies have begun developing prescription and medically formulated Vitamin K2 products. Additionally, the rising prevalence of osteoporosis, Vitamin K deficiency in certain patient groups, and the growing focus on preventive healthcare are accelerating the adoption of pharmaceutical-grade Vitamin K2 and further boosting its popularity.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=80962397
Asia Pacific is projected to be the fastest-growing region in the Vitamin K2 market during the forecast period.
The Asia Pacific region is projected to be the fastest-growing region in the Vitamin K2 market, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region’s rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.
Leading Vitamin K2 Companies:
The report profiles key players such as Gnosis by Lesaffre (France), Balchem Corp. (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Menadiona (Spain), GF Fermentech (South Korea), AngelYeast Co., Ltd. (China), and GeneFerm Biotechnology Co., Ltd. (Taiwan).
Gnosis by Lesaffre
Gnosis by Lesaffre is a global biotechnology company specializing in scientifically validated nutritional ingredients for the human health and wellness industry, with a strong position in the vitamin K2 market. The company’s flagship MenaQ7 vitamin K2 (MK7), produced through a natural fermentation process, is widely recognized for supporting bone and cardiovascular health and is used in dietary supplements and functional nutrition products worldwide. Leveraging Lesaffre’s expertise in fermentation and biotechnology, Gnosis by Lesaffre emphasizes innovation, clinical research, quality assurance, and sustainable production while serving customers across Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa through an extensive global sales and distribution network.
Richen Nutritional Technology Co., Ltd
Richen Nutritional Technology Co., Ltd. is a China-based nutraceutical ingredient manufacturer specializing in the research, development, production, and supply of nutritional ingredients and customized nutrition solutions for the food, beverage, dietary supplement, and medical nutrition industries. In the Vitamin K2 market, the company focuses on innovation, biotechnology, and scientific research to support bone and cardiovascular health applications while offering formulation and manufacturing services to global customers. Richen operates dedicated R&D and application laboratories, collaborates with leading research institutions, adheres to internationally recognized quality management standards, and serves customers across more than 60 countries, strengthening its presence in the global vitamin ingredients market.
GF Fermentech Co., Ltd.
GF Fermentech Co., Ltd. is a South Korea-based biotechnology company specializing in the development, fermentation, and production of high-value functional ingredients for the nutraceutical, pharmaceutical, food, and cosmetic industries. In the Vitamin K2 market, the company leverages its microbial fermentation expertise and advanced bioprocessing capabilities to manufacture high-purity Vitamin ingredients that support bone and cardiovascular health applications. The company emphasizes continuous research and development, quality assurance, and sustainable manufacturing while serving customers across Asia, Europe, North America, and other international markets through a global distribution network.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=80962397
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/vitamin-k2-market-80962397.html
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Vitamin K2 Market Projected to Reach $339.9 million by 2031 | Top Companies are Gnosis by Lesaffre (France) and Balchem Corp (US)
